Comparative pharmacology of dothiepin, its metabolites, and other antidepressant drugs

  title={Comparative pharmacology of dothiepin, its metabolites, and other antidepressant drugs},
  author={David J. Heal and Sharon C. Cheetham and Keith F. Martin and John Browning and Graham P. Luscombe and R. James Buckett},
  journal={Drug Development Research},
The pharmacology of dothiepin and its human metabolites, northiaden, dothiepin sulfoxide, and northiaden sulfoxide, has been studied to determine whether the latter contribute to the therapeutic or side effects profile of the parent tricyclic antidepressant. In vitro, dothiepin was a potent noradrenaline and 5‐hydroxytryptamine (5‐HT) uptake inhibitor, while its secondary amine metabolite, northiaden, was selective for noradrenaline. However, the sulfoxide metabolites were almost inactive as… 
Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects
This review examines the genetically variable CYP450-mediated metabolism of a number of serotonin-active drugs that are often implicated in cases of serotonin toxicity, to assess the impact of pharmacogenetics on drug metabolism, response, interactions and adverse effects.
A comparison of the effects on central 5‐HT function of sibutramine hydrochloride and other weight‐modifying agents
Results show that sibutramine powerfully enhances central 5‐HT function via its secondary and primary amine metabolites; this effect, like that of fluoxetine, is almost certainly mediated through 5‐ HT uptake inhibition.
Metabolites: have we MIST out the importance of structure and physicochemistry?
The analysis of circulating metabolites is driven by the need to complete a comprehensive PK/PD exploration of the activity of a drug to determine the likelihood of the metabolites exerting on and off target pharmacology, which may contribute to the overall efficacy and side effects of the drug.
Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding
The present survey compares the effects of antidepressants and their principal metabolites on reuptake of biogenic amines and on receptor binding to suggest that both dopaminergic and noradrenergic components play a role and that the hydroxybupropion metabolite contributes significantly to the antidepressant activity.
Method Development and Validation for the Estimation of Dothiepin Hydrochloride by Using RP-HPLC in PURE and Tablet Dosage Form
Aim: A simple, sensitive, accurate and precise RP-HPLC method was developed for the determination of Dothiepin HCl (DTH) in pure and tablet dosage form. Methods: The method was developed by using


Steady-State Serum Concentrations of Dothiepin and Northiaden after Two Dosage Regimens of Dothiepin Hydrochloride (Prothiaden)
The study showed that the two regimens yielded similar steady-state serum concentrations both of drug and metabolite but inter-individual differences were large, with one exception, to be very similar after both regimens.
Correlation between plasma diphenhydramine level and sedative and antihistamine effects
There was a positive correlation between plasma diphenhydramine level and sedative and antihistamine effects, but wide variation in the extent and rate of change of these effects were observed between the subjects.
Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.
The role of protein binding and diffusion barriers in the causation of the difference in the results obtained with the two preparations is discussed.
Pirenzepine distinguishes between different subclasses of muscarinic receptors
Binding studies using a new anti-muscarinic drug, pirenzepine, are used, in which heterogeneity of binding is found that correlates well with the pharmacological activity and cannot be taken as evidence for different receptor subtypes.
Metabolism and pharmacokinetics of dothiepin.
Dothiepin S-oxide was the major metabolic reaching a peak level of 81(34-150) microgram/l at 5(4-6) h while that for northiaden was 33 (22-60) h.